Skip to main content
logo
Medexus Pharmaceuticals Inc. (MEDXF)
OTCMKTS · Delayed Price · Currency is USD
2.271
-0.029 (-1.27%)
Jul 3, 2025, 12:44 PM EDT

Medexus Pharmaceuticals Revenue

In the fiscal year ending March 31, 2025, Medexus Pharmaceuticals had annual revenue of $108.33M, down -4.18%. Medexus Pharmaceuticals had revenue of $24.75M in the quarter ending March 31, 2025, a decrease of -4.65%.

Revenue
108.33M
Revenue Growth
-4.18%
P/S Ratio
0.68
Revenue / Employee
1.19M
Employees
82
Market Cap
73.73M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2025108.33M-4.72M-4.18%
Mar 31, 2024113.05M4.96M4.59%
Mar 31, 2023108.10M31.40M40.93%
Mar 31, 202276.70M-2.96M-3.71%
Mar 31, 202179.66M24.15M43.52%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Endo, Inc. 1.73B
Veradigm 588.02M
Elite Pharmaceuticals 84.04M
Tian'an Technology Group 1.78M
Glass House Brands 215.62M
American Oncology Network 1.76B
Northwest Biotherapeutics 1.47M
Silence Therapeutics 27.70M
Revenue Rankings

Medexus Pharmaceuticals News

More News